Lori Fantry, MD, MPH
![](/sites/default/files/styles/az_medium/public/2023-10/fantry-lori-md_inf-dis_cropped_4x6.jpg.webp?itok=f73275H3)
Dr. Fantry joined the University of Arizona in 2016, and was previously the medical director of the University of Maryland/Institute of Human Virology HIV clinic, which provides HIV and hepatitis C care to over 1,800 patients per year. She was also involved with HIV clinical research and education and continues to be active in these areas at the University of Arizona.
Her work has resulted in 27 peer-reviewed publications, multiple book chapters and abstracts at major conferences. Dr. Fantry is currently involved in a study looking at laboratory testing in HIV-infected patients, and is an investigator in the NIH-sponsored study “Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults (REPRIEVE).”
Degree(s)
- MD: State University of New York, Upstate Medical University, Syracuse, 1985
- MPH: Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, 1995
- AB: Princeton University, 1980
HIV prevention, epidemiology, clinical care